 |
|
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
Hye-Kyung Cho
Clin Exp Pediatr. 2021;64(9):459-467. Published online 2021 Feb 10 DOI: https://doi.org/10.3345/cep.2020.01305
|
|
Citations to this article as recorded by
 The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
Maodong Leng, Junmei Yang, Juanjuan Zhou
Frontiers in Pediatrics.2023;[Epub] CrossRef Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
Yun Jung Choi, Eun Hee Chung, Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yoojung Cho, Ju-Hee Seo, In Suk Sol, Myongsoon Sung, Dae Jin Song, Young Min Ahn, Hea Lin Oh, Jinho Yu, Sungsu Jung, Kyung Suk Lee, Ju Suk Lee
Journal of Clinical Medicine.2022; 11(2): 306. CrossRef Association of children wheezing diseases with meteorological and environmental factors in Suzhou, China
Jia-qi Huang, Jin Zhang, Chuang-li Hao, Zheng-rong Chen
Scientific Reports.2022;[Epub] CrossRef Efficacy of Gamma Globulin Combined with Azithromycin Sequential Therapy in the Treatment of RMPP and Its Effect on Th1/Th2 Cytokine Levels
Jie Qi, Fang Jia, Hui Tian, Shengmei Yang, Pan Zheng
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef
|